Hedge Fund - Avidity Partners Management
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $9,478,420 | 1.81% | 85,700 | $126.68 |
| 2 | 2024 - Q4 (2024-12-31) | $30,084,600 | 2.95% | 220,400 | $123.68 |
| 3 | 2024 - Q3 (2024-09-30) | $53,001,200 | 2.7% | 460,000 | $137.09 |
| 4 | 2024 - Q2 (2024-06-30) | $67,595,970 | 2.87% | 491,000 | $137.14 |
| 5 | 2024 - Q1 (2024-03-31) | $73,994,080 | 2.38% | 536,500 | $136.57 |
| 6 | 2023 - Q4 (2023-12-31) | $86,698,080 | 3.15% | 658,000 | $115.11 |
| 7 | 2023 - Q3 (2023-09-30) | $73,361,250 | 2.95% | 652,100 | $105.30 |
| 8 | 2023 - Q2 (2023-06-30) | $62,739,299 | 2.19% | 665,316 | $97.71 |
| 9 | 2023 - Q1 (2023-03-31) | $82,565,154 | 2.74% | 815,700 | $104.06 |
| 10 | 2022 - Q4 (2022-12-31) | $212,603,200 | 4.6% | 1,780,000 | $117.13 |
| 11 | 2022 - Q3 (2022-09-30) | $197,094,000 | 4% | 1,855,700 | $101.46 |
| 12 | 2022 - Q2 (2022-06-30) | $143,062,000 | 3.28% | 1,467,600 | $92.29 |
| 13 | 2022 - Q1 (2022-03-31) | $108,750,000 | 2.26% | 1,160,000 | $84.75 |
| 14 | 2021 - Q4 (2021-12-31) | $107,314,000 | 2.27% | 1,260,000 | $91.99 |
| 15 | 2021 - Q3 (2021-09-30) | $81,418,000 | 1.8% | 848,900 | $94.46 |
| 16 | 2021 - Q2 (2021-06-30) | $66,275,000 | 1.79% | 681,000 | $95.85 |
| 17 | 2021 - Q1 (2021-03-31) | $50,706,000 | 1.4% | 521,400 | $104.86 |
| 18 | 2020 - Q4 (2020-12-31) | $28,755,000 | 0.93% | 300,000 | $96.59 |
| 19 | 2020 - Q3 (2020-09-30) | $0 | 0% | 0 | $115.68 |
| 20 | 2020 - Q2 (2020-06-30) | $22,582,000 | 1.44% | 185,100 | $110.51 |
| 21 | 2020 - Q1 (2020-03-31) | $8,482,000 | 1.17% | 98,000 | $97.87 |
| 22 | 2019 - Q4 (2019-12-31) | $3,547,000 | 2.23% | 33,000 | $104.70 |
The displayed share prices are average quarterly stock market prices.